Home › Meningioma › Virginia › Arlington
Meningioma clinical trials in Arlington, VA
4 studies for Meningioma are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi away
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- Inova Center for Personalized Health, Fairfax · 11 mi away
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- INOVA Health, Fairfax · 11 mi away
Meningioma trials in other cities
- New York City, NY8 studies
- San Francisco, CA7 studies
- Miami, FL7 studies
- Columbus, OH6 studies
- Boston, MA6 studies
- Atlanta, GA5 studies
- San Diego, CA5 studies
- Jacksonville, FL5 studies
- Houston, TX4 studies
- Detroit, MI4 studies
- Durham, NC4 studies
- Phoenix, AZ4 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer111 studies
- Colorectal Cancer54 studies
- Metastatic Cancer52 studies
- Cancer (all types)52 studies
- Breast Cancer50 studies
- Ovarian Cancer47 studies
- Lung Cancer42 studies
- Endometrial Cancer41 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Small Cell Lung Cancer22 studies
- Triple-Negative Breast Cancer21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.